CODX vs MELI · rev $3.9M vs P/E 43, rev $20.78B
Co-Diagnostics, Inc. Common Stock (CODX) versus MercadoLibre Inc. (MELI) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
MercadoLibre Inc. (MELI) is a internet retail company listed on NASDAQ.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported MELI revenue for 2024-12-31 was $20.78B. Net income was $1.91B. Revenue was up 387.6% from 2023-12-31 to 2024-12-31. MELI currently screens at market cap $82.73B and trailing P/E 43.1.
CODX currently screens at market cap $31.4M. MELI currently screens at market cap $82.73B and trailing P/E 43.1.
Not investment advice. Open the CODX and MELI stock pages for the full models.
Not investment advice.